[
  {
    "date": "2023-12-30",
    "symbol": "AKRO",
    "period": "FY",
    "netincomeloss": -151759000,
    "trdarrsecuritiesaggavailamt": 30000,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "entityfilenumber": "001-38944",
    "entityregistrantname": "Akero Therapeutics, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-5266573",
    "entityaddressaddressline1": "601 Gateway Boulevard, Suite 350",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "documentfinstmterrorcorrectionflag": "false",
    "cityareacode": 650,
    "localphonenumber": "487â€‘6488",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "AKRO",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "entitycentralindexkey": 1744659,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "Morristown, NJ",
    "cashandcashequivalentsatcarryingvalue": 234207000,
    "marketablesecuritiescurrent": 315803000,
    "prepaidexpenseandotherassetscurrent": 9952000,
    "assetscurrent": 559962000,
    "marketablesecuritiesnoncurrent": 19283000,
    "propertyplantandequipmentnet": 18000,
    "operatingleaserightofuseasset": 1008000,
    "assets": 580271000,
    "accountspayablecurrent": 7038000,
    "accruedexpensesandothercurrentliabilities": 12090000,
    "liabilitiescurrent": 19128000,
    "longtermloanspayable": 24964000,
    "derivativeliabilitiesnoncurrent": 54000,
    "operatingleaseliabilitynoncurrent": 819000,
    "liabilities": 44965000,
    "commonstockvalue": 6000,
    "additionalpaidincapitalcommonstock": 1109126000,
    "accumulatedothercomprehensiveincomelossnetoftax": 270000,
    "retainedearningsaccumulateddeficit": -574096000,
    "stockholdersequity": 535306000,
    "liabilitiesandstockholdersequity": 580271000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 55754445,
    "commonstocksharesoutstanding": 55754445,
    "researchanddevelopmentexpense": 141798000,
    "generalandadministrativeexpense": 31072000,
    "operatingcostsandexpenses": 172870000,
    "operatingincomeloss": -172870000,
    "interestexpense": 3099000,
    "interestandotherincome": 24210000,
    "marketablesecuritiesunrealizedgainloss": 233000,
    "comprehensiveincomenetoftax": -151526000,
    "earningspersharebasic": -2.89,
    "earningspersharediluted": -2.89,
    "weightedaveragenumberofsharesoutstandingbasic": 52568159,
    "weightedaveragenumberofdilutedsharesoutstanding": 52568159,
    "sharesoutstanding": 55754445,
    "stockissuedduringperiodvaluestockoptionsexercised": 3267000,
    "stockissuedduringperiodsharesstockoptionsexercised": 593959,
    "commonstockissuedforvestedrestrictedstockunits": 38641,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 396000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 12087,
    "stockissuedduringperiodvaluenewissues": 123824000,
    "stockissuedduringperiodsharesnewissues": 3006052,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 330000,
    "stockissuedduringperiodvaluesharebasedcompensation": 21497000,
    "profitloss": -151759000,
    "sharebasedcompensation": 21497000,
    "depreciation": 29000,
    "noncashoperatingleaseexpense": 234000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 9554000,
    "amortizationoffinancingcostsanddiscounts": 448000,
    "fairvalueadjustmentofwarrants": 79000,
    "increasedecreaseindeferredcharges": -337000,
    "foreigncurrencytransactiongainlossunrealized": 8000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6740000,
    "increasedecreaseinaccountspayable": -645000,
    "increasedecreaseinaccruedliabilities": 946000,
    "increasedecreaseinoperatingleaseliability": -231000,
    "netcashprovidedbyusedinoperatingactivities": -145367000,
    "paymentstoacquiremarketablesecurities": 433123000,
    "proceedsfrommaturityofmarketablesecurities": 209500000,
    "netcashprovidedbyusedininvestingactivities": -223623000,
    "proceedsfromstockoptionsexercised": 3267000,
    "proceedsfromissuanceofcommonstockpursuanttoemployeestockpurchaseplan": 396000,
    "proceedsfromissuanceofcommonstockpursuanttoatmoffering": 124212000,
    "proceedsfromissuanceofcommonstockpursuanttoregistereddirectoffering": 211217000,
    "proceedsfromlongtermlinesofcredit": 15000000,
    "paymentoffinancingandstockissuancecosts": 776000,
    "netcashprovidedbyusedinfinancingactivities": 353316000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -15674000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 234207000,
    "interestpaidnet": 2483000,
    "noncashorpartnoncashacquisitionnoncashfinancialorequityinstrumentconsiderationwarrantsissued1": 330,
    "deferredofferingcostsreclassifiedtoadditionalpaidinequity": 364000,
    "numberofplannedclinicaltrials": 3,
    "additionalpaidincapital": 1040200000,
    "proceedsfromissuanceofredeemableconvertiblepreferredstock": 90500000,
    "proceedsfromissuanceinitialpublicoffering": 105800000,
    "proceedsfromissuanceofcommonstock": 818900000,
    "capitalizationlongtermdebtandequity": 25000000,
    "proceedsfromsaleofequitymethodinvestments": 25000000,
    "cashcashequivalentsandshortterminvestments": 569293000,
    "assetsfairvaluedisclosure": 206879000,
    "liabilitiesfairvaluedisclosure": 54000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 206879000,
    "availableforsaledebtsecuritiesgrossunrealizedgain": 255000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 6000,
    "availableforsalesecuritiesdebtsecurities": 206879000,
    "cashandcashequivalentsfairvaluedisclosure": 206879000,
    "marketablesecuritiesincludingcashequivalents": 541965000,
    "marketablesecurities": 335086000,
    "researchanddevelopmentexpensescurrent": 10041000,
    "employeerelatedliabilitiescurrent": 1296000,
    "accruedprofessionalfeescurrent": 231000,
    "shorttermleaseliabilityandothercurrent": 522000,
    "lineofcreditfacilityremainingborrowingcapacity": 10000000,
    "lineofcreditfacilitycovenantterms": "Under the terms of the Loan Agreement, the Company received $10,000 upon closing, $15,000 was borrowed in March of 2023 and $30,000 remains available to the Company to borrow at its sole discretion until March 15, 2024. An additional $45,000 may become available to the Company at Hercules' sole discretion.",
    "maximumpercentageofwarrantspurchased": 0.015,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 36718,
    "recognizedinitialwarrantsatrelativefairvalue": 227000,
    "additionalremainingwarrantswererecognizedatrelativefairvalueatclosingofagreement": 41000,
    "fairvalueassociatedwithequityandliabilityclassifiedwarrants": 268000,
    "warrantsandrightsoutstanding": 54000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 7343000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 16118000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 1539000,
    "longtermdebtoutstandingbeforeendofcharge": 25000000,
    "longtermdebtendoftermcharge": 1463000,
    "debtinstrumentcarryingamountandendoftermcharge": 26463000,
    "unamortizeddebtissuanceexpense": 1499000,
    "loanspayable": 24964000,
    "warrantsandrightsoutstandingterm": "P5Y6M",
    "warrantsandrightsoutstandingmeasurementinput": 0.8322,
    "commonstocknumberofvotingrights": 1,
    "expenserelatedtodistributionorservicingandunderwritingfees": 3578000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1114189,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 28.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1720882,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 28.29,
    "allocatedsharebasedcompensationexpense": 10487000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 51121000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 10331000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y10M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "One-third of the options vest upon achievement of each of the milestones.",
    "descriptionofmilestonesachievedanddeemedvested": "In September 2022, two of the three performance-based awards milestones were achieved and were deemed vested",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 281462,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 24.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodfairvalue": 24030,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0419,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6899977,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 6950,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6899977,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4126549,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 22.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.5,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 49.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 22.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y8M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y8M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y8M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 35133000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 35133000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 28508000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 371952,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 38641,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 28.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 43.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 8685000,
    "deferredtaxassetsoperatinglosscarryforwards": 88219000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 281900000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 12846000,
    "valuationallowancedeferredtaxassetchangeinamount": 68371000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 2118000,
    "deferredtaxassetstaxcreditcarryforwardsresearchderecognized": 87000,
    "unrecognizedtaxbenefits": 3394000,
    "researchanddevelopmentexpendituresamortizationperiod": "P15Y",
    "capitalizationofexpenditurenetofamortizationamount": 65437000,
    "deferredfederalincometaxexpensebenefit": 40292000,
    "deferredstateandlocalincometaxexpensebenefit": 28079000,
    "deferredfederalstateandlocaltaxexpensebenefit": 68371000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.185,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.024,
    "effectiveincometaxratereconciliationotherpermanentdifferences": 0.026,
    "effectiveincometaxratereconciliationchangeinpreferredstocktrancheobligation": -0.445,
    "deferredtaxassetlicensefee": 5545000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 14286000,
    "deferredtaxassetsinprocessresearchanddevelopment": 58610000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 242000,
    "deferredtaxassetsgross": 179748000,
    "deferredtaxassetsvaluationallowance": 177061000,
    "deferredtaxassetsnet": 2687000,
    "deferredtaxliabilitiesprepaidexpenses": 2687000,
    "deferredincometaxliabilities": 2687000,
    "valuationallowancedeferredtaxassetdecreaseamount": 68371000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 223000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1061000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6899977,
    "unrecordedunconditionalpurchaseobligationbalancesheetamount": 30878000,
    "operatingleaseliability": 1079000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent",
    "operatingleaseliabilitycurrent": 260000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 331000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 341000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 351000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 208000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1231000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 152000,
    "operatingleasecost": 324000,
    "shorttermleasecost": 161000,
    "variableleasecost": 37000,
    "leasecost": 522000,
    "operatingleasepayments": 321000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.076
  },
  {
    "date": "2022-12-30",
    "symbol": "AKRO",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "December 31, 2022",
    "entityfilenumber": "001-38944",
    "entityregistrantname": "Akero Therapeutics, Inc.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "81-5266573",
    "entityaddressaddressline1": "601 Gateway Boulevard, Suite 350",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "487â€‘6488",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "AKRO",
    "securityexchangename": "Nasdaq",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "entitycentralindexkey": 1744659,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "Morristown, NJ",
    "cashandcashequivalentsatcarryingvalue": 249773000,
    "marketablesecuritiescurrent": 101676000,
    "prepaidexpenseandotherassetscurrent": 3724000,
    "assetscurrent": 355173000,
    "propertyplantandequipmentnet": 47000,
    "operatingleaserightofuseasset": 1242000,
    "otherassetsnoncurrent": 108000,
    "assets": 356570000,
    "accountspayablecurrent": 7968000,
    "accruedexpensesandothercurrentliabilities": 11115000,
    "liabilitiescurrent": 19083000,
    "longtermloanspayable": 9541000,
    "derivativeliabilitiesnoncurrent": 305000,
    "operatingleaseliabilitynoncurrent": 1079000,
    "liabilities": 30008000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 748857000,
    "accumulatedothercomprehensiveincomelossnetoftax": 37000,
    "retainedearningsaccumulateddeficit": -422337000,
    "stockholdersequity": -422337000,
    "liabilitiesandstockholdersequity": 356570000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 85284000,
    "generalandadministrativeexpense": 29872000,
    "operatingcostsandexpenses": 115156000,
    "operatingincomeloss": -115156000,
    "interestexpense": 739000,
    "othernonoperatingincome": 3862000,
    "netincomeloss": -112033000,
    "marketablesecuritiesunrealizedgainloss": 64000,
    "comprehensiveincomenetoftax": -111969000,
    "earningspersharebasic": -2.87,
    "earningspersharediluted": -2.87,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 5238000,
    "stockissuedduringperiodsharesstockoptionsexercised": 559145,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 280000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 33928,
    "stockissuedduringperiodvaluenewissues": 24647000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalwarrantissued": 227000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 215787000,
    "stockissuedduringperiodvaluesharebasedcompensation": 23243000,
    "netissuancecostandunderwritingfees": 13800000,
    "profitloss": -112033000,
    "sharebasedcompensation": 23243000,
    "depreciation": 43000,
    "noncashoperatingleaseexpense": 217000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 12000,
    "amortizationoffinancingcostsanddiscounts": 204000,
    "fairvalueadjustmentofwarrants": 264000,
    "foreigncurrencytransactiongainlossunrealized": -16000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2112000,
    "increasedecreaseinaccountspayable": 968000,
    "increasedecreaseinaccruedliabilities": -7333000,
    "increasedecreaseinoperatingleaseliability": -206000,
    "netcashprovidedbyusedinoperatingactivities": -92517000,
    "paymentstoacquiremarketablesecurities": 101446000,
    "proceedsfrommaturityofmarketablesecurities": 37621000,
    "netcashprovidedbyusedininvestingactivities": -63825000,
    "proceedsfromstockoptionsexercised": 5016000,
    "proceedsfromissuanceofcommonstockpursuanttoemployeestockpurchaseplan": 280000,
    "proceedsfromissuanceofcommonstock": 25000000,
    "proceedsfromissuanceinitialpublicoffering": 216200000,
    "proceedsfromlongtermlinesofcredit": 10000000,
    "paymentsofdebtissuancecosts": 395000,
    "paymentsforrepurchaseofinitialpublicoffering": 126000,
    "paymentsforrepurchaseofprivateplacement": 212000,
    "paymentsofstockissuancecosts": 131000,
    "netcashprovidedbyusedinfinancingactivities": 255632000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 99290000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 249881000,
    "interestpaidnet": 441000,
    "deferredofferingcostsreclassifiedtoadditionalpaidinequity": 150000,
    "equityissuancecostsincludedinaccountspayableandaccruedexpensesandothercurrentliabilities": 278000,
    "deferredofferingcostsincludedinaccountspayableandaccruedexpensesandothercurrentliabilities": 7000,
    "cashcashequivalentsandshortterminvestments": 351449000,
    "restrictedcashnoncurrentlease": 108000,
    "shortterminvestments": 41834000,
    "assetsfairvaluedisclosure": 96169000,
    "liabilitiesfairvaluedisclosure": 305000,
    "debtsecuritiesavailableforsaleamortizedcostcurrent": 292140000,
    "availableforsaledebtsecuritiesgrossunrealizedgain": 38000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 2000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 292176000,
    "cashandcashequivalentsfairvaluedisclosure": 190500000,
    "marketablesecurities": 292176000,
    "researchanddevelopmentexpensescurrent": 9789000,
    "employeerelatedliabilitiescurrent": 804000,
    "accruedprofessionalfeescurrent": 197000,
    "shorttermleaseliabilityandothercurrent": 325000,
    "lineofcreditfacilitycovenantterms": "Under the terms of the Loan Agreement, the Company received $10,000 upon closing, $15,000 was borrowed on March 10, 2023 and an additional $10,000 is available to the Company at its sole discretion. An additional $20,000",
    "maximumpercentageofwarrantspurchased": 0.015,
    "lineofcreditfacilityremainingborrowingcapacity": 10000000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 36718,
    "recognizedinitialwarrantsatrelativefairvalue": 227000,
    "additionalremainingwarrantswererecognizedatrelativefairvalueatclosingofagreement": 41000,
    "fairvalueassociatedwithequityandliabilityclassifiedwarrants": 268000,
    "warrantsandrightsoutstanding": 305000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1710000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 3725000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 4169000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 396000,
    "longtermdebtoutstandingbeforeendofcharge": 10000000,
    "longtermdebtendoftermcharge": 1170000,
    "debtinstrumentcarryingamountandendoftermcharge": 11170000,
    "unamortizeddebtissuanceexpense": 1629000,
    "warrantsandrightsoutstandingterm": 6.5,
    "warrantsandrightsoutstandingmeasurementinput": 0.0418,
    "commonstocknumberofvotingrights": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "preferredstocksharesauthorized": "null",
    "preferredstockparorstatedvaluepershare": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 28.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 28.76,
    "allocatedsharebasedcompensationexpense": 23243000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 36164000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5461000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "One-third of the options vest upon achievement of each of the milestones.",
    "descriptionofmilestonesachievedanddeemedvested": "In September 2022, two of the three performance-based awards milestones were achieved and were deemed vested",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 129131,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodfairvalue": 5546000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7459,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0271,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 237618,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 23.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 14.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 7.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 207611000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 148416000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 207611000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 129131,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 42.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 42.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 2.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 7076000,
    "deferredtaxassetsoperatinglosscarryforwards": 235472000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 245963000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1249000,
    "valuationallowancedeferredtaxassetchangeinamount": 41837000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 3632000,
    "deferredtaxassetstaxcreditcarryforwardsresearchderecognized": 43000,
    "unrecognizedtaxbenefits": 2110000,
    "researchanddevelopmentexpendituresamortizationperiod": "15-year",
    "capitalizationofexpenditurenetofamortizationamount": 14728000,
    "deferredfederalincometaxexpensebenefit": 27269000,
    "deferredstateandlocalincometaxexpensebenefit": 14568000,
    "deferredfederalstateandlocaltaxexpensebenefit": 41837000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.13,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.024,
    "effectiveincometaxratereconciliationotherpermanentdifferences": 0.008,
    "effectiveincometaxratereconciliationchangeinpreferredstocktrancheobligation": -0.37200000000000005,
    "deferredtaxassetlicensefee": 3355000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8974000,
    "deferredtaxassetsinprocessresearchanddevelopment": 20803000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 191000,
    "deferredtaxassetsgross": 109477000,
    "deferredtaxassetsvaluationallowance": 108690000,
    "deferredtaxassetsnet": 787000,
    "deferredtaxliabilitiesprepaidexpenses": 787000,
    "deferredincometaxliabilities": 787000,
    "valuationallowancedeferredtaxassetdecreaseamount": 41837000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 51000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 746000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "unrecordedunconditionalpurchaseobligationbalancesheetamount": 7239000,
    "operatingleaseliability": 1310000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent",
    "operatingleaseliabilitycurrent": 231000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 321000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 331000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 341000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 351000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 208000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1552000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 242000,
    "operatingleasecost": 324000,
    "shorttermleasecost": 58000,
    "variableleasecost": 58000,
    "leasecost": 440000,
    "operatingleasepayments": 312000,
    "operatingleaseweightedaverageremainingleaseterm1": 4.6,
    "operatingleaseweightedaveragediscountratepercent": 0.076
  }
]